DekaBank Deutsche Girozentrale - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$1,113
-15.0%
69,9000.0%0.00%0.0%
Q2 2023$1,309
+413.3%
69,9000.0%0.00%
+200.0%
Q1 2023$255
-28.2%
69,9000.0%0.00%0.0%
Q4 2022$355
-99.9%
69,9000.0%0.00%0.0%
Q3 2022$323,000
+7.7%
69,9000.0%0.00%0.0%
Q2 2022$300,000
-9.6%
69,9000.0%0.00%0.0%
Q1 2022$332,000
-29.8%
69,900
+10.1%
0.00%0.0%
Q4 2021$473,000
+35.5%
63,500
+2.4%
0.00%0.0%
Q3 2021$349,000
-13.0%
62,0000.0%0.00%0.0%
Q2 2021$401,000
-19.2%
62,0000.0%0.00%
-50.0%
Q1 2021$496,000
+23.4%
62,0000.0%0.00%0.0%
Q4 2020$402,000
+117.3%
62,000
-31.3%
0.00%
+100.0%
Q2 2019$185,000
-67.1%
90,200
+63.7%
0.00%
-66.7%
Q1 2019$562,000
+179.6%
55,100
+22.2%
0.00%
+200.0%
Q4 2018$201,000
-64.2%
45,100
-18.1%
0.00%
-66.7%
Q3 2018$562,000
-0.4%
55,100
-2.7%
0.00%
-25.0%
Q2 2018$564,000
-7.2%
56,6000.0%0.00%0.0%
Q1 2018$608,000
+95.5%
56,600
+50.1%
0.00%0.0%
Q1 2016$311,000
-48.5%
37,700
-14.7%
0.00%
-42.9%
Q4 2015$604,000
+44.8%
44,200
+1.8%
0.01%
+40.0%
Q3 2015$417,000
-30.8%
43,400
+3.6%
0.01%
-28.6%
Q2 2015$603,000
+67.5%
41,900
+4.2%
0.01%
+75.0%
Q1 2015$360,000
+29.5%
40,200
-13.0%
0.00%0.0%
Q4 2014$278,000
-47.7%
46,200
-8.0%
0.00%
-42.9%
Q3 2014$532,000
-8.7%
50,200
+2.0%
0.01%
-22.2%
Q2 2014$583,000
-25.6%
49,200
-6.3%
0.01%
-25.0%
Q1 2014$784,000
+7.3%
52,500
+8.2%
0.01%0.0%
Q4 2013$731,000
-9.0%
48,500
+2.8%
0.01%
-14.3%
Q3 2013$803,00047,2000.01%
Other shareholders
IMMUNOGEN INC shareholders Q1 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders